What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His scientific interests lie mostly in Transplantation, Internal medicine, Surgery, Hematopoietic stem cell transplantation and Gastroenterology.
His Transplantation research is multidisciplinary, relying on both Survival rate, Immunology, Bone marrow, Total body irradiation and Risk factor.
His studies deal with areas such as Transplantation Conditioning and Oncology as well as Internal medicine.
His Surgery study combines topics in areas such as Aplastic anemia and Comorbidity.
The concepts of his Hematopoietic stem cell transplantation study are interwoven with issues in Cancer, Myeloid, Retrospective cohort study, Hazard ratio and Myelofibrosis.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Neutropenia, Chemotherapy, Anemia and Corticosteroid.
His most cited work include:
- Massively parallel digital transcriptional profiling of single cells (2064 citations)
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia (1233 citations)
- Solid Cancers after Bone Marrow Transplantation (763 citations)
What are the main themes of his work throughout his whole career to date?
H. Joachim Deeg spends much of his time researching Internal medicine, Transplantation, Surgery, Immunology and Hematopoietic stem cell transplantation.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology.
His Transplantation study which covers Total body irradiation that intersects with Toxicity.
H. Joachim Deeg interconnects Aplastic anemia and Cumulative incidence in the investigation of issues within Surgery.
His research integrates issues of Haematopoiesis and Stem cell in his study of Immunology.
The Hematopoietic stem cell transplantation study combines topics in areas such as Cancer, Hematopoietic cell, Retrospective cohort study, Survival analysis and Comorbidity.
He most often published in these fields:
- Internal medicine (88.08%)
- Transplantation (80.52%)
- Surgery (43.48%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (88.08%)
- Oncology (37.20%)
- Transplantation (80.52%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Oncology, Transplantation, Myeloid leukemia and Myelodysplastic syndromes.
His study brings together the fields of Gastroenterology and Internal medicine.
His biological study spans a wide range of topics, including International Prognostic Scoring System, Leukemia, Disease and Cytogenetics.
His Transplantation study integrates concerns from other disciplines, such as Hematopoietic cell, Incidence, Cumulative incidence, Immunology and Chronic myelomonocytic leukemia.
H. Joachim Deeg combines subjects such as Surgery and Cohort with his study of Incidence.
His study looks at the relationship between Immunology and fields such as Survival analysis, as well as how they intersect with chemical problems.
Between 2016 and 2021, his most popular works were:
- Massively parallel digital transcriptional profiling of single cells (2064 citations)
- Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes (277 citations)
- Myelodysplastic syndromes, version 2.2017: Clinical practice guidelines in oncology (153 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
H. Joachim Deeg mostly deals with Internal medicine, Transplantation, Oncology, Myelodysplastic syndromes and Hematopoietic stem cell transplantation.
His work on Gastroenterology expands to the thematically related Internal medicine.
His Transplantation study is concerned with the field of Surgery as a whole.
His Oncology research incorporates themes from International Prognostic Scoring System, Azacitidine, Multivariate analysis and Cancer.
As part of one scientific family, he deals mainly with the area of Myelodysplastic syndromes, narrowing it down to issues related to the Clinical trial, and often Donor lymphocyte infusion and Transplantation Conditioning.
The study incorporates disciplines such as Dose fractionation, Cumulative incidence, Intensive care medicine, Total body irradiation and Breast cancer in addition to Hematopoietic stem cell transplantation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
